Page last updated: 2024-11-05

n-butyl acrylate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

n-Butyl acrylate is an acrylate ester with the formula CH2=CHCO2(CH2)3CH3. It is a colorless liquid with a characteristic odor. It is produced by the esterification of acrylic acid with n-butanol. n-Butyl acrylate is a versatile monomer used in the production of a wide range of polymers and copolymers, including acrylic resins, adhesives, paints, coatings, and elastomers. n-Butyl acrylate is also used in the synthesis of other chemicals, such as plasticizers and surfactants. It is studied extensively for its properties, such as its reactivity, solubility, and compatibility with other monomers. The compound is also studied for its potential health and environmental effects.'

butyl acrylate : An acrylate ester obtained by the formal condensation of the hydroxy group of butan-1-ol with the carboxy group of acrylic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID8846
CHEMBL ID1546388
CHEBI ID3245
SCHEMBL ID15037
MeSH IDM0101399

Synonyms (93)

Synonym
BIDD:ER0366
LS-13309
n-butyl propenoate
wln: 4ov1u1
n-butyl acrylate
nsc-5163
acrylic acid butyl ester
acrylic acid, butyl ester
butyl 2-propenoate
2-propenoic acid, butyl ester
acrylic acid, n-butyl ester
nsc5163
butyl prop-2-enoate
CHEBI:3245 ,
NCGC00091107-01
ai3-15739
butylester kyseliny akrylove [czech]
brn 1749970
nsc 5163
hsdb 305
einecs 205-480-7
acrylic acid n-butyl ester
ccris 3401
un2348
141-32-2
butyl acrylate
butyl acrylate, >=99%, contains 10-60 ppm monomethyl ether hydroquinone as inhibitor
A0142
9003-49-0
AKOS000120041
2-propenoic acid butyl ester
A807751
A845377
NCGC00091107-02
dtxsid6024676 ,
cas-141-32-2
tox21_303296
NCGC00256946-01
dtxcid104676
tox21_201387
NCGC00258938-01
STL280321
butyl acrylates, inhibited [un2348] [flammable liquid]
4-02-00-01463 (beilstein handbook reference)
butyl acrylates, inhibited
butylester kyseliny akrylove
705nm8u35v ,
ec 205-480-7
unii-705nm8u35v
BP-20380
FT-0621881
butyl acrylate [hsdb]
butyl acrylate, n-
butyl acrylate [inci]
n-butyl acrylate [iarc]
n-butyl acrylate [mi]
SCHEMBL15037
butylacrylate
n-butylacrylate
normal butyl acrylate
2-propenoic acid n-butyl ester
n-butyl-acrylate
un 2348
butylacrylate, inhibited
CHEMBL1546388
mfcd00009446
J-519959
butyl acrylate, analytical standard
butyl acrylate, purum, >=99.0% (gc)
butyl acrylate, saj first grade, >=99.0%
n-butyl acrylate, cp,98%
butyl acrylate (stabilized with mehq)
n-butyl acrylate, ar,99%
butyl acrylate, stabilized with mehq
acrylic acid-butyl ester
J-007481
Q343005
butyl acrylate resin
EN300-19865
propensaure-n-butylester
butyl 2-propenate
acrylate de butyle
butyl propenoate
butyl acrylates, stabilized
acrylsaeurebutylester
butyl-2-propenoate
n-butyl acrylat
n-butyl acrylate (iarc)
perm glue
n-butyl 2-propenoate
butyl acrylate, stabilized
acrilato de n-butilo
n-butyl-2-propenoate

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" These toxic effects of the olfactory epithelium and cornea were attributed to the known irritancy of MA and BA."( Chronic toxicity and oncogenicity of inhaled methyl acrylate and n-butyl acrylate in Sprague-Dawley rats.
Klimisch, HJ; Koestner, A; Reininghaus, W, 1991
)
0.52
"To retrospectively assess the frequency of adverse events related to percutaneous preoperative portal vein embolization (PPVE)."( Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients.
Bartoli, JM; de Baere, T; Delpero, JR; Denys, A; Di Stefano, DR; Elias, D; Gillet, M; Gorin, G; Hakime, A; Petit, P; Saric, J; Trillaud, H, 2005
)
0.33
" The adverse events that occurred during PPVE or until planned hepatic surgery was performed or cancelled were retrospectively obtained from clinical, imaging, and laboratory data files in 188 patients (109 male and 79 female patients; mean age, 60 years; range, 16-78 years)."( Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients.
Bartoli, JM; de Baere, T; Delpero, JR; Denys, A; Di Stefano, DR; Elias, D; Gillet, M; Gorin, G; Hakime, A; Petit, P; Saric, J; Trillaud, H, 2005
)
0.33
"PPVE is a safe adjuvant technique for hypertrophy of the initially insufficient liver reserve."( Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients.
Bartoli, JM; de Baere, T; Delpero, JR; Denys, A; Di Stefano, DR; Elias, D; Gillet, M; Gorin, G; Hakime, A; Petit, P; Saric, J; Trillaud, H, 2005
)
0.33
"To compare the influence of water samples collected from various areas on toxic effect of HNS, we examined the toxic effect of two commonly found HNS: p-chloroaniline and butyl acrylate, on Nannochloropsis oculata cultured in seawater collected from Laizhou bay and Jiaozhou bay (China)."( Toxic effect of p-chloroaniline and butyl acrylateon Nannochloropsis oculata based on water samples from two sea areas.
Li, Y; Lin, Y; Miao, J; Pan, L; Wang, X; Wei, S; Wu, J, 2021
)
0.62
" subcordiformis) were used as test organism to evaluate the toxic effect of butyl acrylate on their photosynthetic system."( Toxicity evaluation of butyl acrylate on the photosynthetic pigments, chlorophyll fluorescence parameters, and oxygen evolution activity of Phaeodactylum tricornutum and Platymonas subcordiformis.
Li, Y; Lin, Y; Miao, J; Pan, L; Wang, X; Wei, S; Wu, J, 2021
)
0.62

Dosage Studied

ExcerptRelevanceReference
" The excretion of urinary metabolites was studied in rat dosed intraperitoneally with ethyl acrylate and 1-butyl acrylate."( Biotransformation of acrylates. Excretion of mercapturic acids and changes in urinary carboxylic acid profile in rat dosed with ethyl and 1-butyl acrylate.
Linhart, I; Smejkal, J; Vosmanská, M, 1994
)
0.29
" To obtain a virtually complete metabolic pattern, rats were dosed by a single intraperitoneal dose of 1 mmol/kg 1-butyl [3-13C]acrylate."( Metabolic pathways of 1-butyl [3-13C]acrylate. Identification of urinary metabolites in rat using nuclear magnetic resonance and mass spectroscopy.
Hrabal, R; Linhart, I; Mitera, J; Smejkal, J,
)
0.13
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
acrylate ester
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (8)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency52.75630.000714.592883.7951AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency20.82270.000221.22318,912.5098AID743053
thyroid stimulating hormone receptorHomo sapiens (human)Potency19.95260.001318.074339.8107AID926; AID938
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency21.73070.000214.376460.0339AID720691
estrogen nuclear receptor alphaHomo sapiens (human)Potency61.24530.000229.305416,493.5996AID743069
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency56.57170.023723.228263.5986AID743222
activating transcription factor 6Homo sapiens (human)Potency17.88950.143427.612159.8106AID1159516
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1Homo sapiens (human)Potency2.23870.001815.663839.8107AID894
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1466498Glutathione reactivity assessed as rate constant for total GSH loss by UV-vis spectrophotometric method2017Bioorganic & medicinal chemistry letters, 06-01, Volume: 27, Issue:11
Synthesis, structural characterization and biological activity of novel Knoevenagel condensates on DLD-1 human colon carcinoma.
AID1469819Glutathione reactivity of the compound in DMSO and phosphate buffer assessed as second order rate constant for adduct formation2017Journal of medicinal chemistry, 02-09, Volume: 60, Issue:3
Covalent Modifiers: A Chemical Perspective on the Reactivity of α,β-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition Reactions.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (155)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (7.74)18.7374
1990's12 (7.74)18.2507
2000's41 (26.45)29.6817
2010's75 (48.39)24.3611
2020's15 (9.68)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 43.43

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index43.43 (24.57)
Research Supply Index5.10 (2.92)
Research Growth Index4.99 (4.65)
Search Engine Demand Index64.83 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (43.43)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (1.23%)6.00%
Case Studies3 (1.84%)4.05%
Observational0 (0.00%)0.25%
Other158 (96.93%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]